US patent 0337024, Allison Coffin, Joseph Harding, Leen Kawas, Phillip Uribe, "Novel Lead Compound for Otoprotection: Targeting HGF Signaling with Dihexa", issued 2015-11-26 "Dihexa" (PDF)
Nonetheless, the distinct regional and quantitative differences in fat loss between the sexes highlight the need to consider sex-specific effects in obesity treatment [53]
The test reveals predispositions in GLP-1 receptor and metabolic pathways, not autoimmune disease severity or GLP-1 response in autoimmune patients
MultiCare Connected Care teams up with Tuva Health to optimize patient data
Maintaining Benefits: The Ongoing Phase Once your initial glutathione levels are optimized, the focus shifts to a maintenance phase to sustain the benefits youve achieved
10.2337/diab.26.1.11 Diabetes